Lyra Therapeutics, Inc.

Historical 13F Holders

Symbol
LYRA
CUSIP
55234L105
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 55234L105 since 12/18/2024, largest first.

Filer % of Class Filed
Perceptive Advisors LLC 13D/A
15.6% 8/14/2025
Event 8/12/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Nantahala Capital Management, LLC 13G/A
1.1% 11/14/2024
Event 9/30/2024
Citadel Advisors LLC 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q2 1 300 $26
2025 Q1 59 25.6 M $3.23M
2024 Q4 56 26.9 M $5.54M
2024 Q3 63 32.5 M $8.35M
2024 Q2 53 32.7 M $9.06M
2024 Q1 81 45.6 M $283M
2023 Q4 62 42.4 M $222M
2023 Q3 46 31.9 M $125M
2023 Q2 40 33.7 M $138M
2023 Q1 32 18.9 M $38.1M
2022 Q4 38 19.1 M $59.9M
2022 Q3 39 19.2 M $96.0M
2022 Q2 39 19.3 M $109M
2022 Q1 29 5.02 M $20.2M
2021 Q4 35 5.13 M $22.4M
2021 Q3 38 6.67 M $60.8M
2021 Q2 47 6.98 M $56.0M
2021 Q1 51 7.56 M $87.6M
2020 Q4 45 8.60 M $98.0M
2020 Q3 41 7.66 M $85.7M
2020 Q2 44 7.04 M $79.8M